(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

BD 256084 - SARS-CoV-2 Kit and Analyzer Combo with Veritor Plus Analyzer and Two SARS-CoV-2 Test Kits

BD  # 256084 - SARS-CoV-2 Kit and Analyzer Combo with Veritor Plus Analyzer and Two SARS-CoV-2 Test Kits
Part Number BD 256084
SKU Number CIA8041321
Sell Unit EACH
Ships Within Special Order
List Price $858.00
Enter a valid quantity
Product Description

BD 256084 - SARS-CoV-2 Kit and Analyzer Combo with Veritor Plus Analyzer and Two SARS-CoV-2 Test Kits

The BD 256084 Veritor SARS Kit + Analyzer Combo is a professional point-of-care diagnostic testing package designed to support rapid SARS-CoV-2 testing workflows. This combo includes two BD Veritor SARS-CoV-2 test kits and one BD Veritor Plus Analyzer, giving healthcare facilities an integrated platform for COVID-19 antigen testing and automated digital result interpretation.

The BD Veritor Plus Analyzer helps reduce subjective visual interpretation by reading compatible BD Veritor test devices and providing objective results. This supports consistent testing practices in clinical environments where timely respiratory infection assessment, patient triage, and infection control decisions are important.

This product is intended for professional healthcare use in eligible point-of-care, clinical, and diagnostic testing settings. It is available for Continental US shipment only, and orders are non-cancellable and non-returnable.

Manufacturer256084
ApplicationRespiratory Test Kit
Number of Tests2 X 30 Tests
Sample TypeNasal Swab Sample
Test TypeAntigen Detection

Key Benefits

The BD 256084 combo provides both the analyzer and SARS-CoV-2 test kits in one package, helping facilities implement or expand rapid COVID-19 testing workflows with fewer separate purchasing steps.

The analyzer-based system supports standardized digital result interpretation, helping reduce variability that may occur with visually read rapid tests. This can improve workflow consistency across operators and testing locations.

Rapid SARS-CoV-2 antigen testing can support timely patient evaluation, isolation decisions, infection prevention workflows, employee health screening, and respiratory illness management when used according to current clinical and regulatory guidance.

Compatibility and Applications

The BD 256084 Combo is designed for use with the included BD Veritor Plus Analyzer and compatible BD Veritor SARS-CoV-2 test kits. Facilities should verify the analyzer software, assay compatibility, storage requirements, and current authorization status before use.

Typical applications include COVID-19 antigen testing, respiratory illness evaluation, point-of-care diagnostics, employee health testing, urgent care screening, outpatient testing, and infection prevention support.

This solution is commonly used in urgent care centers, physician offices, outpatient clinics, hospitals, occupational health programs, community health settings, and other professional testing environments.

Usage Guidelines

Use the BD 256084 Veritor SARS Kit + Analyzer Combo only by trained healthcare personnel following BD instructions, facility protocols, applicable CLIA requirements, and current public health guidance.

Before testing, verify analyzer readiness, test kit expiration dates, storage conditions, quality control requirements, and specimen collection instructions. Collect and process specimens only as directed in the applicable BD Veritor SARS-CoV-2 test kit instructions.

Insert the prepared test device into the BD Veritor Plus Analyzer for automated result interpretation. Record and report results according to facility policy and applicable regulatory requirements. Do not use expired, damaged, or improperly stored test materials.

Certifications and Safety Standards

The BD Veritor testing platform is manufactured for professional diagnostic use and is designed to support standardized rapid testing workflows. The analyzer and SARS-CoV-2 test kits should be used only according to current product labeling, quality control requirements, and applicable regulatory authorization.

Healthcare facilities should verify current product status, CLIA requirements, EUA or regulatory authorization where applicable, quality control procedures, and documentation requirements through BD, CIA Medical, or authorized product documentation before implementation.

Comparison with Competitor Products

Compared with visually interpreted rapid COVID-19 antigen tests, the BD Veritor Plus Analyzer provides automated digital result interpretation, helping reduce subjectivity and support more consistent reporting.

Compared with laboratory-based molecular testing, rapid antigen testing may provide faster results at the point of care, supporting quicker operational decisions. However, molecular testing may still be preferred when higher analytical sensitivity is required or when confirmatory testing is indicated by clinical guidance.

Compared with purchasing a separate analyzer and test kits individually, the BD 256084 combo package offers a convenient bundled option for facilities that need both platform hardware and SARS-CoV-2 assay supplies.

Typical User Profile and Application Scenarios

The typical users of BD 256084 include physicians, nurses, medical assistants, laboratory personnel, infection prevention teams, occupational health staff, urgent care clinicians, and other trained professionals performing point-of-care respiratory testing.

Common scenarios include testing patients with respiratory symptoms, pre-procedure screening when permitted by facility policy, employee health testing, urgent care triage, outpatient COVID-19 evaluation, and infection prevention support during respiratory virus activity.

Best Practices for Use and Maintenance

Store the analyzer and SARS-CoV-2 test kits according to BD instructions and maintain required environmental conditions. Rotate inventory by expiration date and inspect all test materials before use.

Train all operators on specimen collection, test processing, analyzer use, quality control, documentation, and result reporting. Maintain records for operator competency, quality control, analyzer maintenance, and test results according to facility policy.

Clean and maintain the analyzer according to manufacturer guidance. Use appropriate personal protective equipment when handling patient specimens and treat all specimens as potentially infectious.

Regulatory and Safety Information

The BD 256084 Veritor SARS Kit + Analyzer Combo is intended for professional diagnostic use only. Testing should be performed by trained personnel in accordance with BD instructions, applicable CLIA requirements, infection control procedures, and current federal, state, and local regulations.

All patient specimens and used test materials should be handled as potentially infectious. Follow standard precautions, approved biohazard disposal procedures, and facility reporting requirements. Facilities should confirm current regulatory status before ordering or using the product.

How to Order

Select the BD 256084 Veritor SARS Kit + Analyzer Combo Including Two SARS-CoV-2 Kits and One Analyzer and add it to your cart. Complete checkout with your preferred shipping and payment options. This product is available for Continental US shipment only, and orders are non-cancellable and non-returnable. For bulk orders, quotes, availability checks, or further assistance, contact CIA Medical customer service at (312) 275-5850 or use the contact form on this page.

Related Products